Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Orbactiv vs Brilacidin - Thx all for clarifying the Seeking Alpha article. I had a chance to read later today and Brilacidin comes off fine, unlike as the headline misleadingly suggests.

The whole kit and caboodle on Orbactiv, for those of us still learning up on it, is detailed in the link below ... Inc the undesirable side effects that biodoc ref'd -- why Brilacidin is the better product

http://www.drugs.com/pro/orbactiv.html

Orbactiv did get quite good press coverage when it launched... CBS, NY Times.

http://www.cbsnews.com/news/new-single-dose-antibiotic-oritavancin-may-help-battle-superbug-mrsa/

http://mobile.nytimes.com/2014/06/05/health/single-dose-of-antibiotic-found-effective-in-quelling-mrsa.html

Here's hoping Brilacidin does too, given the better safety and comparable/better efficacy profile, and all the continued SuperBug talk. Last week I spent some time trying to do as much, contacting various press folks. I'll keep you posted if anything pans out.

To that point, Forbes writer David Kroll, in the below June 2014 story, had indicated much anticipating Brilacidin results when responding to a comment. Guess, six months later with bottomline data out anytime, we're about due fir a followup story.

http://www.forbes.com/sites/davidkroll/2014/06/20/antibiotic-pipeline-revival-fda-approves-cubist-pharmaceuticals-sivextro-for-mrsa-other-serious-skin-infections/

KROLL COMMENT
David Kroll, Contributor 5 months ago
Indeed, Mr. Harvey, other companies are developing single-dose drugs for various infectious disease indications. Oritavancin is one in the vancomycin class. I’ll be very interested to see how brilacidin turns out.

Googling around some more, I came across Orbactiv pharm rep chatter ... Insightful in places if you have the patience to search out the possibly interesting "cooler talk." Looks like The Medicines Company's (what a company name...Farrell90's Cellgen has a better ring to it) main product ain't selling like hotcakes (if commentary is taken as legit)

Comments along the lines of The Street not responding favorably to their Q4 earnings call in late January, when "we have to disclose our shitty Orbactiv sales launch. Pressure will be unbearable in just a few months"

(Btw Just found out IHUB rules prohibit me from posting links or I'd source the above.)

F-farai skiing was good! About 14 inches over last few days. Hope you got some turns in at Alta.

Looking forward to another newsy week for CTIX.